ISTANBUL
Japan on Tuesday announced its first domestic COVID-19 vaccine against the Omicron XBB. 1. 5 coronavirus subvariant. A Health Ministry panel said the vaccine developed through pharmaceutical company Daiichi Sankyo is approved for use, Tokyo-based news firm NHK reported. The panel said, “They have demonstrated the efficacy of the vaccine and have no serious considerations about its safety. “The vaccine will be distributed nationwide in December after receiving approval from the ministry. The ministry approved Daiichi Sankyo’s plan to produce and sell 1. 4 million doses of the vaccine. . Vaccine adapted to XBB. 1. 5, giving rise to the procurement contract.
Out of about 34 million COVID-19 cases since the beginning of 2020, Japan has recorded around 75,000 deaths, according to figures from the Worldometer.